Lmc. Hall et al., OXA-11, AN EXTENDED-SPECTRUM VARIANT OF OXA-10 (PSE-2) BETA-LACTAMASEFROM PSEUDOMONAS-AERUGINOSA, Antimicrobial agents and chemotherapy, 37(8), 1993, pp. 1637-1644
Pseudomonas aeruginosa ABD, which was isolated in October 1991 from bl
ood cultures of a burn patient in Turkey, was resistant to cephalospor
ins, particularly ceftazidime (MIC, 512 mug/ml), penicillins, aztreona
m, and meropenem, but not to imipenem. Cephalosporin and penicillin re
sistance transferred to P. aeruginosa PU21 and was associated with a b
eta-lactamase with a pl of 6.4 encoded by a 100-MDa plasmid designated
pMLH52. Like extended-spectrum TEM and SHV beta-lactamases, this enzy
me hydrolyzed penicillins and newer cephalosporins but did not hydroly
ze cefoxitin or carbapenems. However, it differed from TEM and SHV der
ivatives in being a potent oxacillinase, and its encoding gene did not
hybridize with probes to TEM and SHV genes. To characterize the enzym
e, libraries of total DNA were cloned into plasmid pUC19 and were tran
sformed into Escherichia coli DH5alpha. Recombinant plasmids that gave
ceftazidime resistance all contained a 3.65-kb BamHI fragment. Deleti
ons from this fragment allowed the beta-lactamase gene to be located o
n a 1.4-kb section of DNA, which contained an open reading frame of 79
8 bases. This encoded a protein that was deduced to differ from PSE-2
beta-lactamase only in having serine instead of asparagine at position
143 and aspartate instead of glycine at position 157. It is concluded
that the resistance of isolate ABD depended on an extended-spectrum v
ariant of the PSE-2 enzyme. The ability of this enzyme to cause ceftaz
idime resistance depended primarily on a low K(m) for the compound; V(
max) remained low. It is proposed that PSE-2 should be transferred to
the OXA group as OXA-10 and that the new enzyme be designated OXA-11.